Hoth Therapeutics, Inc. (HOTH)
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Address
590 MADISON AVENUE
NEW YORK, NY 10022
Founded
2017
Number of Employees
6
Website
http://www.hoththerapeutics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)